The authors conducted a 16-week randomized double-blind placebo-controlled trial for geriatric depression in 143 older outpatients diagnosed with major depression comparing treatment response in three treatment groups : methylphenidate plus placebo ( N = 48 ) , citalopram plus placebo ( N = 48 ) , and citalopram plus methylphenidate ( N = 47 ) .